Better Obesity Drug Race: Novo Nordisk vs Lilly 2026
In the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
This piece explains glide path withdrawal strategies for index funds, focusing on steady income while managing sequence of returns risk.
25,847 articlesIn the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
An oversized insider trade at Check Point Software followed a sharp stock decline. Learn how to interpret this move, ...
Take-Two CEO Strauss Zelnick is directing a record-setting $1.5 billion launch budget for GTA VI, a move investors wi...
More Americans 65+ continue to work and fund HSAs, but Medicare Part A backdating can create excess contributions and...
A Jersey Republican is set to reappear in Congress after nearly four months away, citing an unspecified medical condi...
A major shakeup in AI deals spotlights coding as a premier use case for generative AI. Google hires Windsurf talent a...
Brent crude sits near $72.68 a barrel on July 1, 2026, as traders weigh demand trends and ongoing supply discipline. ...
AMD and Marvell released quarterly results centered on AI infrastructure, highlighting different strategic bets in da...
Two market behemoths, two roadmaps: Palantir’s enterprise AI software and SanDisk’s hyperscale memory hardware race t...
Bitcoin rose above $60,000, yet a large inflow of BTC to exchanges suggests the rebound could face renewed selling pr...
Iran’s envoy to China indicates Beijing could receive favorable terms in Hormuz transit, as Tehran coordinates with O...
A blockbuster year for Delek US Holdings brought attention to a notable insider move. The event described as delek in...